BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3521063)

  • 21. Role of radiation therapy in Hodgkin's lymphoma.
    Yahalom J
    Cancer J; 2009; 15(2):155-60. PubMed ID: 19390312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of propes in the combined treatment of malignant lymphomas].
    Kindzel'skiĭ LP; Gubareva AA; Tomilina NA; Sivkovich SA; Ponomareva OV; Naĭshtetik VIa
    Lik Sprava; 1997; (4):146-7. PubMed ID: 9471360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemo- and radiotherapy of patients with different types of malignant neoplasms].
    Aliev BM
    Med Radiol (Mosk); 1986 Jun; 31(6):11-4. PubMed ID: 3523097
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diagnosis and treatment of Hodgkin's lymphoma (HL) in children].
    Kolygin BA
    Vopr Onkol; 2002; 48(3):269-73. PubMed ID: 12455347
    [No Abstract]   [Full Text] [Related]  

  • 25. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
    Yahalom J
    J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
    [No Abstract]   [Full Text] [Related]  

  • 26. Twenty-year disease and treatment-associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3-month anthracycline-based chemotherapy followed by extended high-dose radiation.
    Sénécal D; Jais JP; Desablens B; Berthou C; Casassus P; Moles MP; Delwail V; Gastinne T; Colonna P; Andrieu JM
    Cancer; 2008 Feb; 112(4):846-55. PubMed ID: 18072259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemotherapy or combined modality treatment: the optimal treatment for Hodgkin's disease.
    Diehl V
    J Clin Oncol; 2004 Jan; 22(1):15-8. PubMed ID: 14657229
    [No Abstract]   [Full Text] [Related]  

  • 28. Combined modality treatment of Hodgkin's lymphoma.
    Klimm B; Engert A
    Cancer J; 2009; 15(2):143-9. PubMed ID: 19390310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A trial of using farmorubicin in the therapy of malignant lymphomas].
    Abdyldaev RA; Bauér IG; Dyĭkanbaeva SK
    Ter Arkh; 1992; 64(7):49-52. PubMed ID: 1440368
    [No Abstract]   [Full Text] [Related]  

  • 30. Current strategies in the treatment of childhood Hodgkins disease.
    Arya LS; Dinand V
    Indian Pediatr; 2005 Nov; 42(11):1115-28. PubMed ID: 16340052
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Late effects from radiation therapy: the hits just keep on coming.
    Aleman BM; de Bruin ML; Dorresteijn LD; Krol AD; van 't Veer MB; Boogerd W; van Leeuwen FE
    J Natl Cancer Inst; 2010 Apr; 102(8):576-7; author reply 577-8. PubMed ID: 20308649
    [No Abstract]   [Full Text] [Related]  

  • 32. [Radiological methods in malignant lymphomas].
    Riessbeck KH; Hoppe D; Mau S
    Z Arztl Fortbild (Jena); 1975 Mar; 29(6):298-302. PubMed ID: 1220306
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment for early-stage hodgkin lymphoma: has radiotherapy had its day?
    Radford J
    J Clin Oncol; 2012 Nov; 30(31):3783-5. PubMed ID: 23008306
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined cytostatic and radiological therapy of systemic diseases (malignant lymphomas)].
    Kob D; Kob G
    Radiobiol Radiother (Berl); 1970; 11(2):155-60. PubMed ID: 4928131
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy of malignant lymphoma].
    Sampi K
    Rinsho Hoshasen; 1985 Oct; 30(11):1364-74. PubMed ID: 3910876
    [No Abstract]   [Full Text] [Related]  

  • 36. Uncertainties in contemporary treatment of aggressive lymphomas.
    Cox JD; Ha CS; Lee HK; Dabaja BS; Wilder RB
    Rays; 2003; 28(3):289-92. PubMed ID: 15018315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of B-cell non-Hodgkin's malignant lymphomas of childhood in Europe: recent and on-going studies.
    Lemerle J
    IARC Sci Publ; 1985; (60):383-98. PubMed ID: 3905590
    [No Abstract]   [Full Text] [Related]  

  • 38. Involved field radiotherapy for limited stage Hodgkin lymphoma: balancing treatment efficacy against long-term toxicities.
    Goda JS; Tsang RW
    Hematol Oncol; 2009 Sep; 27(3):115-22. PubMed ID: 19274613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances and changes in the treatment of non-malignant Hodgkin lymphoma in children].
    Armata J
    Pol Tyg Lek; 1983 Oct 17-24; 38(42-43):1331-4. PubMed ID: 6371737
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autologous transplantation of peripheral blood stem cells in malignant lymphomas].
    Sánchez Luceros A; Koziner B
    Medicina (B Aires); 1995; 55(4):366-72. PubMed ID: 8728879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.